1. Home
  2. PBT vs SPTX Comparison

PBT vs SPTX Comparison

Compare PBT & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Permian Basin Royalty Trust

PBT

Permian Basin Royalty Trust

N/A

Current Price

$31.51

Market Cap

1.0B

Sector

Energy

ML Signal

N/A

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$19.84

Market Cap

929.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PBT
SPTX
Founded
1980
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
929.8M
IPO Year
N/A
2026

Fundamental Metrics

Financial Performance
Metric
PBT
SPTX
Price
$31.51
$19.84
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $37.00
AVG Volume (30 Days)
78.3K
★ 175.4K
Earning Date
11-11-2026
11-13-2026
Dividend Yield
★ 0.87%
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$57.37
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.25
$15.79
52 Week High
$37.00
$28.38

Technical Indicators

Market Signals
Indicator
PBT
SPTX
Relative Strength Index (RSI) 36.82 49.17
Support Level $30.72 $18.72
Resistance Level $32.25 $22.75
Average True Range (ATR) 1.15 1.42
MACD -0.22 0.38
Stochastic Oscillator 6.26 61.98

Price Performance

Historical Comparison
PBT
SPTX

About PBT Permian Basin Royalty Trust

Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole, and others across Texas. The company earns the majority of its revenue in the form of royalties received through its properties.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: